Here are relevant reports on : ai-in-business-administration-market
-
Cloud AI Market by Cloud AI Infrastructure (Compute, Storage, Network), AI & ML Platforms (Auto ML), MLOps and Lifecycle Management (AI Workflow Orchestration), AIaaS, Technology (Generative AI and Other AI) - Global Forecast to 2029
The global cloud AI market is projected to reach USD 327.15 billion by 2029 at a CAGR of 32.4 % during the forecast period. Some of the significant cloud AI vendors include Google (US), IBM (US), AWS (US), Microsoft (US), Oracle (US), NVIDIA (US), Salesforce (US), SAP (Germany), Alibaba Cloud (China), HPE (US), and Intel (US).
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
AI as a Service Market by Product Type (Chatbots & AI Agents, ML Framework, API, No Code/Low Code Tools, Data Labeling), Service Type (ML as a Service, NLP as a Service, Generative AI as a Service), Business Function, End User - Global Forecast to 2030
The AI as a service (AIaaS) market is projected market USD 91.20 billion by 2030, featuring a CAGR of 35.1% during the forecast period. The major players in the AI as a Service market include Microsoft (US), IBM (US), Google (US), AWS (US), OpenAI (US), NVIDIA (US), Salesforce (US), Oracle (US), SAP (Germany), and HPE (US).
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Conversational AI Market by Product Type (AI Chatbots, Voice Bots, Virtual Assistants, Gen AI Agents), Business Function (Sales & Marketing, Operations & Supply Chain, Finance & Accounting, HR), Integration Type, and End User - Global Forecast to 2031
The conversational AI market is set for significant expansion and is expected to grow from USD 17.05 billion in 2025 to USD 49.80 billion by 2031, indicating a strong CAGR of 19.6% during the forecast period. The major players in the conversational AI market include Microsoft (US), IBM (US), Google (US), OpenAI (US), Baidu (China), Boost.ai (Norway), Verloop.io (India), OneReach.ai (US), Omilia (Cyprus), and Aisera (US).
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Pediatric Vascular Access Market by Type (Catheters (CVC, PIVC, PICC), Ports, IV Sets, Infusion Pumps), Application (Drug Administration, Blood Transfusion, Diagnostics & Testing), End User (Hospitals, ASCs) - Global Forecast to 2030
The global pediatric vascular access market, valued at US$0.51 billion in 2023, stood at US$0.54 billion in 2024 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$0.83 billion by the end of the period. The market for pediatric vascular access is driven by the increasing prevalence of preterm births, and advancements in pediatric care technologies are key factors fueling the growth of the pediatric vascular access market.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Stomach Cancer Treatment Market by Treatment, Type (Chemotherapy, Immunotherapy), Disease Indication (Gastric Cancer), Route of Administration, Drug Class (PD-1/PD-L1 inhibitors, HER2 antagonists), Distribution Channel - Global Forecast to 2027
The global stomach cancer treatment market is projected to reach USD 8 billion by 2027 from USD 4 Billion in 2022, at a CAGR of 14% during the forecast period
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Middle East & Africa Pharmaceutical Drug Delivery Market by Route of Administration (Injectable [Syringe, Auto injector], Oral [Tablet, Capsule, Syrup], Topical, Nasal, Ocular, Rectal), Application (Cancer, Diabetes, CVD, Ophthalmic) - Forecast to 2031
The Middle East & Africa Pharmaceutical Drug Delivery market, valued at USD 37.39 billion in 2025, stood at USD 38.20 billion in 2026 and is projected to advance at a resilient CAGR of 4.8% from 2026 to 2031, culminating in a forecasted valuation of USD 48.22 billion by the end of the period. The Middle East & Africa pharmaceutical drug delivery market is expanding steadily due to the modernization of healthcare infrastructure and the growing adoption of patient-friendly treatment modalities.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Hemophilia Treatment Market by Indication (Type A, Type B), Therapy (Replacement (Recombinant, Plasma Derived), Route of Administration, End User - Global Forecast to 2027
The global hemophilia treatment market is projected to reach USD ~15 billion by 2027 from USD 12 Billion in 2022, at a CAGR of 5% during the forecast period. The major players in the global hemophilia market are Bayer Healthcare (Germany), Octapharma AG (Switzerland), Novo Nordisk (Denmark), Kedrion (Italy), Pfizer Inc. (US), Biogen (US) among others.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Europe Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), and End User (Hospitals, Clinics) – Forecast to 2031
The Europe veterinary vaccines market, valued at USD3.84 billion in 2025, stood at USD4.08 billion in 2026 and is projected to advance at a resilient CAGR of 6.6% from 2026 to 2031, culminating in a forecasted valuation of USD5.61 billion by the end of the period. The growth of the market is driven by the increased pet ownership and greater emphasis on animal welfare.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Pharmaceutical Drug Delivery Market by Route of Administration (Oral, Injectors (Auto Injectors), Implantable, Transmucosal, Nasal, Syringes), Application (Cancer, Diabetes), Care Setting (Hospital, Home Care) - Forecast to 2031
The Asia Pacific pharmaceutical drug delivery market, valued at US$457.9 million in 2025, stood at US$479.7 million in 2026 and is projected to advance at a resilient CAGR of 7.5% from 2026 to 2031, culminating in a forecasted valuation of US$687.9 million by the end of the period. The market growth for drug delivery in the APAC region is steadily expanding due to an increase in disease prevalence, an increase in the adoption rate of biologics, advancements in technologies, and an increase in regional production.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Vascular Access Device Market Type [Central, Peripheral (Venous {PIVC, Midline}, Arterial), Intraosseous], Route of Insertion, Application [Chemotherapy, Fluid Administration, Diagnostic], End User [Hospital (Public, Private)] - Global Forecast to 2031
The global vascular access device market is projected to reach USD 8.70 billion by 2031, growing at a CAGR of 6.7% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: February 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
